{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:45:32Z","timestamp":1784335532322,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"The National Institutes of Health","doi-asserted-by":"crossref","award":["R21 CA175950"],"award-info":[{"award-number":["R21 CA175950"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10549-019-05182-3","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T06:49:30Z","timestamp":1551854970000},"page":"579-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["What does risk of future cancer mean to breast cancer patients?"],"prefix":"10.1007","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6550-5240","authenticated-orcid":false,"given":"Karen","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzie A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia F.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilani","family":"Lacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Karavites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"5182_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1245\/s10434-016-5408-8","volume":"23","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F, Margenthaler JA, Song DH, Staley AC, Wilke LG, Willey SC, Yao KA (2016) Contralateral prophylactic mastectomy consensus statement from the American society of breast surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol 23:1\u20136. \n                    https:\/\/doi.org\/10.1245\/s10434-016-5408-8","journal-title":"Ann Surg Oncol"},{"issue":"9472","key":"5182_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative G (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(05)66544-0","journal-title":"Lancet"},{"issue":"12","key":"5182_CR3","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1245\/s10434-015-4442-2","volume":"22","author":"PR Portschy","year":"2015","unstructured":"Portschy PR, Abbott AM, Burke EE, Nzara R, Marmor S, Kuntz KM, Tuttle TM (2015) Perceptions of contralateral breast cancer risk: a prospective, longitudinal study. Ann Surg Oncol 22(12):3846\u20133852. \n                    https:\/\/doi.org\/10.1245\/s10434-015-4442-2","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"5182_CR4","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-011-1914-x","volume":"18","author":"A Abbott","year":"2011","unstructured":"Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18(11):3129\u20133136. \n                    https:\/\/doi.org\/10.1245\/s10434-011-1914-x","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"5182_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/1055-9965.EPI-09-1051","volume":"19","author":"Y Liu","year":"2010","unstructured":"Liu Y, P\u00e9rez M, Aft RL, Massman K, Robinson E, Myles S, Schootman M, Gillanders WE, Jeffe DB (2010) Accuracy of perceived risk of recurrence among patients with early-stage breast cancer. Cancer Epidemiol Biomark Prevent 19(3):675\u2013680. \n                    https:\/\/doi.org\/10.1158\/1055-9965.epi-09-1051","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"3","key":"5182_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","volume":"265","author":"SM Wong","year":"2017","unstructured":"Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M (2017) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265(3):581\u2013589. \n                    https:\/\/doi.org\/10.1097\/sla.0000000000001698","journal-title":"Ann Surg"},{"issue":"1","key":"5182_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jamcollsurg.2014.03.043","volume":"219","author":"CE Pesce","year":"2014","unstructured":"Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K (2014) Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the national cancer data base. J Am Coll Surg 219(1):19\u201328. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.03.043","journal-title":"J Am Coll Surg"},{"issue":"9","key":"5182_CR8","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/jama.2014.10707","volume":"312","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Lichtensztajn DY, Keegan TM, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in california, 1998\u20132011. JAMA 312(9):902\u2013914. \n                    https:\/\/doi.org\/10.1001\/jama.2014.10707","journal-title":"JAMA"},{"key":"5182_CR9","unstructured":"National Comprehensive Cancer Network (2016) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Breast Cancer"},{"key":"5182_CR10","doi-asserted-by":"publisher","unstructured":"Lostumbo L, Carbine NE, Wallace J (2010) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (11):Cd002748. \n                    https:\/\/doi.org\/10.1002\/14651858.CD002748.pub3","DOI":"10.1002\/14651858.CD002748.pub3"},{"issue":"2","key":"5182_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-014-3160-y","volume":"148","author":"I Jatoi","year":"2014","unstructured":"Jatoi I, Parsons HM (2014) Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res Treat 148(2):389\u2013396. \n                    https:\/\/doi.org\/10.1007\/s10549-014-3160-y","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"5182_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.7326\/0003-4819-159-6-201309170-00003","volume":"159","author":"SM Rosenberg","year":"2013","unstructured":"Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, Winer EP, Partridge AH (2013) Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med 159(6):373\u2013381. \n                    https:\/\/doi.org\/10.7326\/0003-4819-159-6-201309170-00003","journal-title":"Ann Intern Med"},{"key":"5182_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2013.5689","author":"ST Hawley","year":"2014","unstructured":"Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ (2014) Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg. \n                    https:\/\/doi.org\/10.1001\/jamasurg.2013.5689","journal-title":"JAMA Surg"},{"issue":"5","key":"5182_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.amjsurg.2011.01.018","volume":"201","author":"E Han","year":"2011","unstructured":"Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, Nelson J (2011) Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg 201(5):615\u2013618. \n                    https:\/\/doi.org\/10.1016\/j.amjsurg.2011.01.018","journal-title":"Am J Surg"},{"key":"5182_CR15","doi-asserted-by":"publisher","unstructured":"Han PKJ, Hootsmans N, Neilson M, Roy B, Kungel T, Gutheil C, Diefenbach M, Hansen M (2013) The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancer. BMJ Open 3(9). \n                    https:\/\/doi.org\/10.1136\/bmjopen-2013-003226","DOI":"10.1136\/bmjopen-2013-003226"},{"issue":"4","key":"5182_CR16","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0360-3016(03)00203-7","volume":"56","author":"X Gao","year":"2003","unstructured":"Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Rad Oncol Biol Phys 56(4):1038\u20131045. \n                    https:\/\/doi.org\/10.1016\/s0360-3016(03)00203-7","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"15","key":"5182_CR17","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","volume":"27","author":"SJ Anderson","year":"2009","unstructured":"Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, Geyer CE Jr, Wickerham DL, Costantino JP, Wolmark N (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 27(15):2466\u20132473. \n                    https:\/\/doi.org\/10.1200\/JCO.2008.19.8424","journal-title":"J Clin Oncol"},{"issue":"3","key":"5182_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12282-015-0595-x","volume":"23","author":"N Tamura","year":"2016","unstructured":"Tamura N, Tsuda H, Yoshida M, Hojo T, Akashi-Tanaka S, Kinoshita T, Sugihara K (2016) Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ. Breast Cancer 23(3):510\u2013518. \n                    https:\/\/doi.org\/10.1007\/s12282-015-0595-x","journal-title":"Breast Cancer"},{"issue":"3","key":"5182_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1023\/A:1021853302033","volume":"77","author":"E Rakovitch","year":"2003","unstructured":"Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, Pritchard KI, Ho C, Redelmeier DA (2003) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 77(3):285\u2013293. \n                    https:\/\/doi.org\/10.1023\/a:1021853302033","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5182_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1756-9966-28-157","volume":"28","author":"A Caruso","year":"2009","unstructured":"Caruso A, Vigna C, Marozzo B, Sega FM, Sperduti I, Cognetti F, Savarese A (2009) Subjective versus objective risk in genetic counseling for hereditary breast and\/or ovarian cancers. J Exp Clin Cancer Res 28(1):157. \n                    https:\/\/doi.org\/10.1186\/1756-9966-28-157","journal-title":"J Exp Clin Cancer Res"},{"key":"5182_CR21","doi-asserted-by":"publisher","DOI":"10.1089\/gte.2004.8.139","author":"K Kelly","year":"2004","unstructured":"Kelly K, Leventhal H, Marvin M, Toppmeyer D, Much J, Dermody J, Baran J, Schwalb M (2004) Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1\/2 mutations. Genet Test. \n                    https:\/\/doi.org\/10.1089\/gte.2004.8.139","journal-title":"Genet Test"},{"issue":"4","key":"5182_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1023\/A:1023905106360","volume":"12","author":"K Kelly","year":"2003","unstructured":"Kelly K, Leventhal H, Toppmeyer D, Much J, Dermody J, Marvin M, Baran J, Schwalb M (2003) Subjective and objective risks of carrying a BRCA1\/2 mutation in individuals of Ashkenazi Jewish descent. J Genet Couns 12(4):351\u2013371. \n                    https:\/\/doi.org\/10.1023\/a:1023905106360","journal-title":"J Genet Couns"},{"issue":"12","key":"5182_CR23","first-page":"1005","volume":"5","author":"IM Lipkus","year":"1996","unstructured":"Lipkus IM, Rimer BK, Strigo TS (1996) Relationships among objective and subjective risk for breast cancer and mammography stages of change. Cancer Epidemiol Biomark Prevent 5(12):1005\u20131011","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"6","key":"5182_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/NCC.0b013e3181dc37a1","volume":"33","author":"NJ Park","year":"2010","unstructured":"Park NJ, Kang DH, Weaver MT (2010) Objective and subjective breast cancer risk: relationships with natural killer cell activity and psychological distress in healthy women. Cancer Nurs 33(6):411\u2013420. \n                    https:\/\/doi.org\/10.1097\/NCC.0b013e3181dc37a1","journal-title":"Cancer Nurs"},{"issue":"4 Suppl","key":"5182_CR25","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1037\/0278-6133.24.4.S35","volume":"24","author":"P Slovic","year":"2005","unstructured":"Slovic P, Peters E, Finucane ML, Macgregor DG (2005) Affect, risk, and decision making. Health Psychol 24(4 Suppl):S35\u2013S40. \n                    https:\/\/doi.org\/10.1037\/0278-6133.24.4.s35","journal-title":"Health Psychol"},{"key":"5182_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.4.286","author":"C Lerman","year":"1995","unstructured":"Lerman C, Lustbader E, Rimer B (1995) Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst. \n                    https:\/\/doi.org\/10.1093\/jnci\/87.4.286","journal-title":"J Natl Cancer Inst"},{"key":"5182_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/jnci\/89.2.148","volume":"89","author":"C Lerman","year":"1997","unstructured":"Lerman C, Biesecker B, Benkendorf J, Al E (1997) Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89:148\u2013157","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5182_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev.publhealth.24.100901.141005","volume":"24","author":"JH Hibbard","year":"2003","unstructured":"Hibbard JH, Peters E (2003) Supporting informed consumer health care decisions: data presentation approaches that facilitate the use of information in choice. Ann Rev Public Health 24(1):413\u2013433. \n                    https:\/\/doi.org\/10.1146\/annurev.publhealth.24.100901.141005","journal-title":"Ann Rev Public Health"},{"issue":"3","key":"5182_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/obhd.1996.0077","volume":"67","author":"CK Hsee","year":"1996","unstructured":"Hsee CK (1996) The evaluability hypothesis: an explanation for preference reversals between joint and separate evaluations of alternatives. Org Behav Human Decis Process 67(3):247\u2013257. \n                    https:\/\/doi.org\/10.1006\/obhd.1996.0077","journal-title":"Org Behav Human Decis Process"},{"issue":"Supplement 1","key":"5182_CR30","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.pec.2010.07.041","volume":"81","author":"BJ Zikmund-Fisher","year":"2010","unstructured":"Zikmund-Fisher BJ, Fagerlin A, Ubel PA (2010) Risky feelings: why a 6% risk of cancer does not always feel like 6%. Patient Educ Couns 81(Supplement 1):S87\u2013S93. \n                    https:\/\/doi.org\/10.1016\/j.pec.2010.07.041","journal-title":"Patient Educ Couns"},{"issue":"20","key":"5182_CR31","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1002\/cncr.28260","volume":"119","author":"SJ Katz","year":"2013","unstructured":"Katz SJ, Morrow M (2013) Addressing overtreatment in breast cancer. Cancer 119(20):3584\u20133588. \n                    https:\/\/doi.org\/10.1002\/cncr.28260","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05182-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05182-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05182-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:14:37Z","timestamp":1589721277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05182-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5182"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05182-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human subjects were in accordance with the ethical standards of the Northwestern University Institutional Review Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}